What is the platform worth? Part of treatment for all solid tumors operable and inoperable. Cannot put a price on it now not knowing the impact. Just look at the presentation slide of all the adjuvants it can be paired with if people think this is unreasonable. Not my slide. Scientific presentation.
Calls for $12 earlier as a reasonable buyout is not realistic for the full platform. Have to go it alone or make a partnership(s) agreement. But I cannot deny management seems to always cuck-up. Especially their messaging on May 10th. No excuse for the clown show.
How in the world is there a buyout when the 1st of several treatments is still in the womb? This is a platform, not a one and done. This is a partnering situation- up front payment with Class C issued and ongoing split of revenue. This is a long play not a buyout at this juncture.